These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2488179)

  • 21. Structural and ultrastructural peritoneal membrane changes and permeability alterations during continuous ambulatory peritoneal dialysis.
    Verger C; Brunschvicg O; Le Charpentier Y; Lavergne A; Vantelon J
    Proc Eur Dial Transplant Assoc; 1981; 18():199-205. PubMed ID: 7329968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peritoneal morphology in children treated by continuous ambulatory peritoneal dialysis.
    Schneble F; Bonzel KE; Waldherr R; Bachmann S; Roth H; Schärer K
    Pediatr Nephrol; 1992 Nov; 6(6):542-6. PubMed ID: 1482642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diabetic changes in the stria vascularis in humans--a study of PAS-stained temporal bone sections].
    Tomisawa H
    Nihon Jibiinkoka Gakkai Kaiho; 2000 Nov; 103(11):1227-37. PubMed ID: 11187757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipoprotein (a) levels in patients undergoing continuous ambulatory peritoneal dialysis.
    Guindeo C; Vega N; Fernandez AM; Palop L; Aguilar JA; Moreda A; Cia P
    Perit Dial Int; 1996; 16 Suppl 1():S236-40. PubMed ID: 8728199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of the uremic diabetic.
    Shyh TP; Beyer MM; Friedman EA
    Nephron; 1985; 40(2):129-38. PubMed ID: 3889674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spontaneous and induced diabetic microangiopathy.
    Bloodworth JM; Engerman RL
    Acta Diabetol Lat; 1971 Sep; 8 Suppl 1():263-301. PubMed ID: 4259866
    [No Abstract]   [Full Text] [Related]  

  • 27. [Continuous ambulatory peritoneal dialysis: is long-term therapy possible?].
    Olszowska A; Antosiewicz S; Pietrzak B
    Pol Merkur Lekarski; 2000 Dec; 9(54):845-8. PubMed ID: 11255652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-mediated immunity in uremic patients prior to and after 6 months' treatment with continuous ambulatory peritoneal dialysis.
    Shohat B; Boner G; Waller A; Rosenfeld JB
    Isr J Med Sci; 1986; 22(7-8):551-5. PubMed ID: 3491060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetic patients on CAPD need less aluminum hydroxide as a phosphate binder than non-diabetics.
    Macia M; Coronel F; Torrente J; Sanchez A; Tornero F; Barrientos A
    Adv Perit Dial; 1990; 6():50-2. PubMed ID: 1982839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of factors in the prognosis of diabetics on continuous ambulatory peritoneal dialysis (CAPD): long-term experience.
    Coronel F; Hortal L; Naranjo P; Pozo C; Torrente J; Prats D; Barrientos A
    Perit Dial Int; 1989; 9(2):121-5. PubMed ID: 2488197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis of peritoneal fibrosis and peritoneal small vessel changes.
    Nakamoto M
    Perit Dial Int; 1996; 16 Suppl 1():S39-41. PubMed ID: 8728160
    [No Abstract]   [Full Text] [Related]  

  • 32. Peritoneal accumulation of AGE and peritoneal membrane permeability.
    Park MS; Lee HA; Chu WS; Yang DH; Hwang SD
    Perit Dial Int; 2000; 20(4):452-60. PubMed ID: 11007378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variability of peritoneal protein loss in diabetic and nondiabetic patients on continuous ambulatory peritoneal dialysis.
    Spaia S; Christidou F; Pangidis P; Tsoulkas T; Pazarloglou M; Pappa A; Vayonas G
    Perit Dial Int; 1993; 13 Suppl 2():S242-4. PubMed ID: 8399578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in water transport across the peritoneum during treatment with continuous ambulatory peritoneal dialysis in selected patients with and without peritonitis.
    Radtke M; Albrektsen GE; Widerøe TE; Nilsen TI; Romundstad P; Hallan S; Aasarød K; Laegreid IK; Oien C
    Perit Dial Int; 2004; 24(6):571-9. PubMed ID: 15559487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Xylitol as osmotic agent in CAPD: an alternative to glucose for uremic diabetic patients?
    Bazzato G; Coli U; Landini S; Fracasso A; Morachiello P; Righetto F; Scanferla F; Onesti G
    Trans Am Soc Artif Intern Organs; 1982; 28():280-6. PubMed ID: 6761936
    [No Abstract]   [Full Text] [Related]  

  • 36. [Changes in the renal glomerular capillaries in alloxan diabetes in rats].
    Baranov VG; Sokoloverova IM; Chembartseva AN
    Probl Endokrinol (Mosk); 1972; 18(4):50-6. PubMed ID: 4652136
    [No Abstract]   [Full Text] [Related]  

  • 37. Experimental diabetic microangiopathy. I. Basement membrane statistics in the dog.
    Bloodworth JM; Engerman RL; Powers KL
    Diabetes; 1969 Jul; 18(7):455-8. PubMed ID: 5795027
    [No Abstract]   [Full Text] [Related]  

  • 38. Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties.
    Plum J; Hermann S; Fusshöller A; Schoenicke G; Donner A; Röhrborn A; Grabensee B
    Kidney Int Suppl; 2001 Feb; 78():S42-7. PubMed ID: 11168981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Complications in diabetic patients on dialysis: experiences in 10 years of treatment using 3 technics].
    Coronel F; Hortal L; Horcajo P; Naranjo P; del Pozo C; Torrente J; Barrientos A
    Rev Clin Esp; 1989 Mar; 184(5):225-9. PubMed ID: 2772292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CAPD in end stage patients with renal disease due to diabetes mellitus--an update.
    Tzamaloukas AH; Yuan ZY; Balaskas E; Oreopoulos DG
    Adv Perit Dial; 1992; 8():185-91. PubMed ID: 1361783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.